000623.SZ
吉林敖东
SZSE · Healthcare · C 制造业 · CN
CNY 17.98
+0.06%Year over year
Reported trailing growth
- Revenue
- -6.1%
- EBITDA
- —
- EBIT
- +43.0%
- EPS
- +43.6%
- Free cash flow
- +210.9%
- Operating cash flow
- +77.1%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -6.6%
- EBITDA
- +25.2%
- EBIT
- +28.9%
- Net income
- +10.4%
- EPS
- +9.2%
- Free cash flow
- -2.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026